Qualigen Therapeutics Inc.

NASDAQ: QLGN
Share price (1/8/25): $4.17
Market cap (1/8/25): $3.071 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 59 pages Stock Purchase Agreement by and Among Qualigen Therapeutics, Inc., Chembio Diagnostics, Inc., Biosynex, S.A., and Qualigen, Inc., Dated as of July 20, 2023

from 8-K 14 pages Contingent Value Rights Agreement

from 8-K 13 pages Contingent Value Rights Agreement

from 425 13 pages Contingent Value Rights Agreement

from 8-K 95 pages Agreement and Plan of Merger Among: Ritter Pharmaceuticals, Inc., a Delaware Corporation; Rpg28 Merger Sub, Inc., a Delaware Corporation; and Qualigen, Inc., a Delaware Corporation Dated as of January 15, 2020

from 425 95 pages Agreement and Plan of Merger Among: Ritter Pharmaceuticals, Inc., a Delaware Corporation; Rpg28 Merger Sub, Inc., a Delaware Corporation; and Qualigen, Inc., a Delaware Corporation Dated as of January 15, 2020